Cabergoline
Overview
Cabergoline is a long-acting dopamine receptor agonist used primarily in the treatment of disorders associated with hyperprolactinemia, including prolactin-secreting adenomas. It has been found effective in reducing prolactin levels and tumor size.
API suppliers (7)
Suppliers of Cabergoline evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 7 suppliers.
1 of 7 holds a GMP certificate on record in the EU or UK registers
- CF PHARMA LTD1 active DMF
- TAPI NL BVNetherlands1 active DMF
- Apotex Pharmachem India Pvt. Ltd.India
- Pfizer Inc.United States
- IVAX CR
- MYLAN LABORATORIES LTD GMP on record
- Gedeon Richter Usa
Therapeutic areas
Do you supply Cabergoline? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.